



 Cytokinins are plant hormones involved in numerous growth and development 
processes, such as cell division, leaf senescence, shoot initiation and growth, cell 
development, and biotic and abiotic stress responses5.  The cytokinin signaling pathway 
(Figure 1) in plants is similar to the two-component phosphorelay systems commonly 
found in prokaryotes.  In plants, this pathway is initiated when cytokinin binds to the 
CHASE domain of an ARABIDOPSIS HISTIDINE KINASE (AHK), which causes 
autophosphorylation of a histidine residue contained within its kinase domain. This 
phosphate is subsequently transferred to an aspartic acid contained within the receptor’s 
receiver domain. The phosphate group is then transferred to an ARABIDOPSIS 
HISTIDINE PHOSPHOTRANSFER PROTEIN (AHP), which takes the phosphate group 
into the nucleus to phosphorylate the aspartic acid of ARABIDOPSIS RESPONSE 
REGULATORS (ARR).  There are two types of ARRs: type-A ARRs, which lack DNA 
binding domains and act as negative regulators of this signaling pathway, and type-B 
ARRs, which control the expression of cytokinin-regulated genes, including the type-A 
ARRs5. 
Recent evidence has suggested that cytokinin can activate type-B ARR’s by a 
mechanism independent of a phosphorylated aspartic acid.  A type-B ARR double mutant 
line, arr1,12, is hyposensitive to cytokinin.  Introduction of wild-type (WT) ARR12 
rescued type-B ARR function in the mutant plants.  However, introduction of 
ARR12:D69N, in which the aspartic acid was replaced by the non-phosphorylatable 
asparagine, also rescued function in the plants, though to a lesser extent than the ARR12 
(unpublished data). An alternative possible mechanism is phosphorylation through 
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serine/threonine (Ser/Thr) residues in addition to the canonical Asp residue. To explore 
this possibility, analysis of ARR12 and ARR12:D69E on Phos-tag gels exhibited several 
retarded bands, which is consistent with several sites of phosphorylation. Upon 
inspection, it was noted that there were several Ser/Thr residues within the receiver 
domain of ARR12. After creating phospho-mimics of these sites, it was found that these 
mutants can activate the cytokinin signaling pathway in the absence of cytokinin.  
Altogether, this data supports the notion that phosphorylation of serine and threonine may 
act as an alternative mechanism to aspartic acid phosphorylation in the cytokinin 
signaling pathway (unpublished data). 
To identify the Ser/Thr kinase that may act in cytokinin signaling, we took 
inspiration from the ethylene signaling pathway (Figure 2), which involves a His kinase 
coupled to a Ser/Thr kinase. In the absence of ethylene, the ethylene receptors (ETR1, 
ERS1, ETR2, EIN4, and ERS2), which are His kinases, act as negative regulators by 
interacting with and activating a Ser/Thr kinase called CONSTITUTIVE TRIPLE 
RESPONSE 1 (CTR1).  CTR1 phosphorylates ETHYLENE INSENSITIVE 2 (EIN2), 
which is then degraded. In the presence of ethylene, ethylene receptors undergo a 
conformational change to inactivate CTR1, and CTR1 no longer functions to repress 
EIN2.  Thus, EIN2 is free to signal to the next part of the pathway and activate 
transcription factors that regulate various primary and secondary ethylene response 
genes4. Interestingly, the CTR1 protein kinase has several paralogs, which we have 
termed CTR1-LIKE SEQUENCES (CLS) (Figure 3). Other than CTR1, the only CLS 
gene characterized to date is ENHANCED DISEASE RESISTANCE 1 (EDR1). EDR1 
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functions as a negative regulator in disease resistance, stress response signaling, and cell 
death regulation3.  The other CLS genes currently have unknown functions.   
Since CTR1 is a Ser/Thr kinase that is regulated by the ethylene receptors, which 
are two-component histidine kinases similar to the cytokinin receptors, we hypothesize 
that the CLS genes, including EDR1, may encode Ser/Thr kinases that can phosphorylate 
type-B ARRs in the cytokinin signaling pathway. In this report, I made use of two reverse 
genetics approaches, CRISPR-Cas9 and T-DNA insertional mutagenesis, to knockout the 
CLS genes to determine if they function in the hypothesized Ser/Thr phosphorylation.  
Clustered Regularly Interspaced Short Palindromic Sequences (CRISPR)-Cas9 is genome 
editing tool that has recently been developed in plants.  It utilizes a synthetic guide RNA 
that recruits the Cas9 enzyme to induce site-specific DNA cleavage and generate 
insertion/deletion (in/del) mutations through the cell's error prone DNA repair program8.  
As an alternative approach to CRISPR-Cas9 and to isolate additional mutant alleles for 
each target gene, I am also screening the T-DNA insertional mutant libraries. The T-
DNA libraries consist of large numbers of random insertion events of the Agrobacterium 
T-DNA into the Arabidopsis genome. These insertion events have been mapped onto the 
genome, and the libraries are publicly available1. To date, I have isolated 1 heterozygous 
and 6 homozygous cls mutant lines using the T-DNA approach as well as obtained 4 
homozygous cls mutations via the CRISPR-Cas9 method. 
Methods and Materials 
CLS CRISPR T0 Seed Screen: 
T0 seeds were surface sterilized in 70% ethanol and 0.1% Triton-x-100 solution for 10 
minutes.  The seeds were then rinsed three times with 1 mL of 70% ethanol. The seeds 
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were dried in the laminar flow hood and plated on Gamborg B5 media plates containing 
Basta (10 μg/mL). After the seeds were stratified for at least 2 days at 4˚C in the dark, the 
plates were transferred to the Percival growth chamber under full light conditions at 
22˚C. Putative T1 transformants were transferred to pots and grown under full day 
fluorescent light to maturity, self-pollinated, and harvested for seed. 
 
CLS CRISPR T2 and T3 Screen: 
T1 and T2 seed was prepared in the same manner as T0 seeds were. For T1 seed (T2 
plants), 10 days after germination, plates were analyzed for a 3:1 segregation ratio of 
living to dead seeds to determine if the plants were single copy transformants.  Plants 
from plates that did not meet this segregation were not further studied, and only plants 
from plates with the desired segregation ratio were selected to be grown in pots under 
fluorescent light. 
 
CLS CRISPR T2 Heat Stress Growth Protocol: 
T1 and T2 seed were prepared as described above.  The heat stress treatment was 
performed as previously described6.  Briefly, the plants were grown with four periods of 
heat stress, in which the plants were placed in 37˚C heat (30 hours) and then 22˚C (40 
hours) under long day (18 hours lights/6 hours dark) fluorescent light conditions.  The 
first heat stress period started four days after the plants were transferred to pots. After the 
final heat stress period, plants were grown in long day fluorescent light growth conditions 







Three glass beads were added to tubes, and about 2 cm2 of plant leaves were added to the 
tubes.  The tubes were placed in the GenoGrinder for 30 seconds at 1500 rpm to 
homogenize the leaves.  DNA Extraction buffer (200 mM Tris-HCl pH 7.5, 250 mM 
NaCl, 25 mM EDTA, 0.5% SDS) was added to each tube (500 µL), and the tubes were 
centrifuged for 5 minutes at 14,000 rpm.  Cleared supernatant (300 µL) was transferred to 
a new tube, and 300 µL of isopropanol was added to each tube.  After sitting at room 
temperature for 5 minutes, the tubes were centrifuged for 5 minutes at 14,000 rpm to 
pellet the DNA.  The supernatant was poured off, and 300 µL of 70% ethanol was added 
to each tube.  The tubes were centrifuged again for 3 minutes at 14,000 rpm.  The 
supernatant was poured off, the tubes were dried for 30 minutes, and the DNA was re-
suspended in 100 µL of water.  The tubes of DNA were stored at 4˚C. 
 
PCR Amplification and Digestion with dCAPS: 
Extracted plant DNA was used for PCR analysis by either genotyping or dCAPs analyses. 
For genotyping PCR, I used primers designed for the Basta resistance gene (Table 1) and 
checked for presence/absence of amplified band. For dCAPs analysis, primers were 
designed for the predicted cut site (3-4 bases upstream from the PAM) for each target 
CLS gene (Table 1).  The DNA was amplified using Red Taq polymerase (Genesee 
Scientific Corp., San Diego).  After amplification for dCAPs analysis, the DNA was 
digested with the appropriate restriction digest enzyme. The digested amplified DNA 
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were run on a 3% agarose gel for 30 minutes at 130V and compared to digested and 
undigested amplified products from wild-type Columbia (Col-0) lines of Arabidopsis.  
 
PCR Amplification and Gel Analysis of T-DNA Insertion Lines: 
DNA extracted from T-DNA insertion plants were amplified in three different reactions 
using 3 different primer pairs: forward and reverse primers, forward and left border 
primers, and left border and reverse primers. The forward and reverse primers were 
designed for the CLS targets, and the left border primer was designed for the specific T-
DNA insertion (Table 2).  The reactions were run on a 1% agarose gel for 20 minutes at 
130V and compared to amplified products from wild-type Columbia (Col-0) lines of 
Arabidopsis.  
Results  
Three different plasmids were constructed in plant transformation vectors that 
contained tandem guide RNAs targeting the various CLS genes (Figure 3).  The guide 
RNAs were designed to incorporate an in/del mutation in an exon upstream from the 
kinase domain. The first plasmid, CLSA.1, contained guide RNAs for AT3G58640, 
AT2G31010, and AT2G4264.  The second plasmid, CLSB.1, contained guide RNAs for 
CTR1 and AT4G24480.  The third plasmid, CLSB.2, contained gRNAs for AT1G73660, 
AT1G18160, AT5G11850, and AT1G08720.  After selecting for the BASTA resistance 
carried on the transgene, 13 independent T1 CRISPR transformants were generated for 
the CLSA.1 line, 10 independent transformants were generated for the CLSB.1 line, and 
13 were generated for the CLSB.2 line (Tables 3, 4, and 5, respectively). Interestingly, no 
apparent phenotypes were observed in any of the transformants at either the T1 or T2 
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stages, suggesting relatively poor editing of the CLS target genes or poor Cas9 construct 
design. Using a dCAPs method7, I screened all targets from all three plant lines.  
Strikingly, and consistent with the lack of phenotypes, I did not observe Cas9 editing in 
any of the 45 screened CLSB.1 plants nor at the first three targets of the 42 screened 
CLSB.2 plants (Tables 4, 5, 7, and 8). However, I observed significant Cas9 editing at the 
fourth target of CLSB.2 plants at the AT1G08720 (ENHANCED DISEASE RESISTANCE 
1; EDR1)3 gene in both T1 and T2 plants (Table 5, Table 8, and Figure 4).  Additionally, 
I did not observe Cas9 editing at the first or third targets in any of the 34 CLSA.1 plants, 
but low levels of Cas9 editing were found at the second target, AT2G31010, in two 
plants: CLSA.1 4-3 (T1 plant) and CLSA.1 9-2-5 (T2 plant) (Table 3, Table 6, and Figure 
7). Thus, Cas9 editing seemed to be stochastic and an inefficient means to obtain cls 
mutants in our hands, which could be attributed to poorly designed guide RNAs. 
Recently, a group has demonstrated that elevated temperature could increase Cas9 
editing efficiencies in plants6. Significant increases in Cas9 editing efficiencies were 
observed when plants were grown under periods of heat stress, likely because the Cas9 
enzyme is derived from bacteria that grow optimally at higher temperatures than that at 
which we normally grow Arabidopsis, and the Cas9 is likely much more active at this 
higher temperature. To test the efficacy of this approach, I regrew and retested the 
progeny from the T1 and T2 transformants with marginal editing at the second target, 
AT2G31010, of the CLSA.1 line with the heat stress growth protocol. These plants were 
subjected to 4 periods of 37˚C heat treatment for 30 hours followed by a resting phase of 
22˚C for 40 hours. Using dCAPs on the 5 CLSA.1 plants (T2s: 4-3-2, 4-3-3, 4-3-4; T3s: 
9-2-5-2, 9-2-5-7) grown under heat stress conditions, I found significantly increased Cas9 
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editing efficiency and have obtained homozygous mutations at all 3 genes in all of the 
plants (Figure 9 and Table 11). The heat stressed CLSA.1 lines displayed reduced growth 
and seed yield, but this may be attributed to the heat stress treatment rather than the 
mutations. Whether these phenotypes are attributed to the mutations or heat stress 
treatment will be teased out in the next generation of plants that will be grown without 
heat stress. I am currently growing T2 transformants with heat stress periods for the 
CLSB.1 and CLSB.2 lines. 
As an alternative approach to CRISPR-Cas9 and to isolate additional mutant 
alleles for each target gene, I am screening the T-DNA insertional mutant libraries1. I 
tried to select T-DNA lines in which the insertion is located in an exon toward the 5’ end 
of the CLS genes, which tend to generate complete null mutants. However, some T-DNA 
lines I am screening have insertions in introns and downstream exons, which may yield 
complete null or hypomorphic alleles or have no effect. This will be determined by qPCR 
analysis of the CLS transcript to determine the nature of the T-DNA alleles. Through T-
DNA insertional mutagenesis, I have identified T-DNA mutants for 7 out of 9 of the 
target CLS genes: 6 homozygous mutants and 1 heterozygous mutant (Table 10).  The 
only phenotype observed was seen in at2g31010 (CLSA.1-2), which displays a mutant 
yellow seed phenotype, reminiscent of TRANSPARENT TESTA2, compared to the brown 
seed of Col-0 lines (Figure 6).  We hope to find a second mutant allele for this gene to 
determine if the phenotype is due to the T-DNA insertion. 
Discussion 
 In this report, I describe how I am using two reverse genetics approaches to obtain 
cls mutants: CRISPR-Cas9 editing and T-DNA insertional mutagenesis. Interestingly, I 
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observed low Cas9 editing efficiencies when plants were grown under normal conditions 
(i.e. without heat stress treatment). Using dCAPs analysis, I found two edited genes out 
of the nine tested CLS genes in both the T1 and T2 generations.  The sole edited gene 
discovered in the CLSB.2 plants was found in the EDR1 gene, which is a CTR1-like 
kinase involved in disease resistance, stress response signaling, and cell death regulation3. 
The dCAPs gel for these events shows that they are heterozygous for the edited gene with 
some homozygous mutants (Figure 4).  No observable phenotypes were seen in any of 
the EDR1 mutants. The other edited gene was found as a somatic mutation in two plants 
from the CLSA.1 plants at the AT2G31010 gene (Figure 7). When I introduced heat stress 
treatment to the progenies of these CLSA.1 lines, I noticed significantly increased Cas9 
editing efficiencies.  In the five heat-stressed CLSA.1 plants that I tested, all of them 
showed homozygous editing at all three target genes (Figure 9 and Table 11), whereas 
only two out of the previous 34 CLSA.1 plants without heat stress treatment showed 
slight editing at only one of the target genes (Figure 7). This increase in editing events 
was consistent with previous research that claims that heat stress increases editing 
efficiency up to 100-fold in Arabidopsis6. Thus, we fully expect to obtain CRISPR-Cas9 
knockouts for all CLS genes using this heat stress growth protocol. The heat stressed 
CLSA.1 plant lines displayed reduced growth; however, this may have been caused by 
the heat stress treatment.  Thus, I plan to measure phenotypes for these mutations in the 
next generation.  Also, I plan to segregate this triple mutant out to generate the 
corresponding single and double mutant combinations.  Lastly, I am in the process of 




 From the T-DNA insertion method, we discovered homozygous mutants in six out 
of nine target genes and a heterozygous mutant in one other target gene (Table 10).  
Interestingly, the only cls T-DNA single mutant that displayed a phenotype was 
at2g31010, which displays a yellow seed coat phenotype that is different from the brown 
seed coat observed in Col-0 plants (Figure 6).  This phenotype is most likely due to a lack 
of pigmentation in the seed coat and referred to as TRANSPARENT TESTA.  Specifically, 
proanthrocyanidins, which appear brown in color, are not produced in the bioflavin 
synthesis pathway in plants with a TRANSPARENT TESTA phenotype2.  Future directions 
include determining whether this phenotype is cause by the T-DNA insertion by 
obtaining a second mutant allele for the AT2G31010 gene and then determining the 
precise role of AT2G31010 in regulating bioflavin biosynthesis and whether it also 
functions in the cytokinin signaling pathway. 
Although I obtained several cls mutants, I only identified one mutant phenotype.  
This may be due to the genetic redundancy of the CLS genes.  Since these genes are 
paralogs of each other, the proteins that they encode may perform similar functions.  
Knocking out one CLS gene may not produce an observable phenotype since having 
functional copies of the other genes may be sufficient for the plant to function normally. 
Moreover, the growth conditions that we use may not generate any phenotypes, as the 
genes may function in response to stressors, similar to EDR13. In the future, I hope to 
identify more phenotypes from both T-DNA insertional mutants and CRISPR-Cas9 




After isolating knockout lines and performing crosses to generate multiple 
combinatorial mutants to eliminate genetic redundancy, I will assess whether these 
homozygous mutants are involved in the cytokinin signaling pathway. To do this, I will 
use the traditional cytokinin response root elongation assay, which involves growing 
mutants on several different concentrations of cytokinin.  Comparing the root lengths of 
mutant plants to WT plants in the assay allows us to determine whether the mutants are 
involved in the cytokinin signaling pathway. If these CLS genes do encode ser/thr kinases 
that act in the cytokinin signaling pathway, I expect cls knockout mutants to 
phosphorylate less Ser/Thr residues and, therefore, be hyposensitive to cytokinin9.  Thus, 
I would expect root length of the mutants to be longer than WT plants, which is 
consistent with previous cytokinin hyposensitive mutants10. 
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Table 1. dCAPs primers used in dCAPs analysis. Note: the restriction enzyme is listed for each dCAPs 
primer pair. 
Restriction Enzyme Primer DNA Sequence 
CLSA1-1 DdeI F ACGGGAGATGATGCTGGGCCATCT 
CLSA1-1 DdeI R2 AGTACTAGATGTCTCTTCTTGCGATC 
CLSA1-2 DRAIII F TTTCCGCAAGTTCTGATCCACGG 
CLSA1-2 DRAIII R2 CTTTTGGGGTAAAGAGATGGTGAG 
CLSA1-3 BslI F2 AGAAGTTGAGAAGATATACGTGCCTCC 
CLSA1-3 BslI F3 AGAAGTTGAGAAGATATACGTGCCTGCC 
CLSA1-3 BslI R2 ACCCAGTACTCCAAAAAATATTCGATG 
    
CLSB1-1 BsII F AGGCGGATTTGATTGGGATCCTCCC 
CLSB1-1 BslI R2 ACTGGATTGCCTTTGCAACCCTAG 
CLSB1-2 BsII F ATGCCTCACCGGACTACTTACTCC 
CLSB1-2 BslI R2 TCTTTGAAATCCAAAACTCTCTCCAAC 
    
CLSB2-1 BsII F CATCTTCATACTCCAAATGCTAGAACAACCA 
CLSB2-1 BslI R2 TCCGGGGAGGAATTAGGGTTTATG 
CLSB2-2 BslI F TTCGTATCACGCCCAATCAACCA 
CLSB2-2 BslI R2 ATTCAGAGTTATCTTGAGACCTCAATG 
CLSB2-3 BslI F GCTCAAATGTATCCAGTCTCGGCCTT 
CLSB2-3 BslI R2 ATCGATCCTAGCCCTATTCTTAGTAC 
CLSB2-4 Hpy166II F GAGAGCGATGAAGCATATTTTCAAGAAGGT 
CLSB2-4 Hpy16611 R2 AGGAGGATTAGCAGAAACGTGAATC 
  
Basta - F AGAAACCCACGTCATGCCAGTTC 
Basta - R ACATCGAGACAAGCACGGTCAAC 
 
Table 2. Primers used for genotyping T-DNA insertional mutants. 
CLS Target Gene T-DNA Primer Primer Sequence 
CLSA.1-1 At3g58640 At3g58640 - F TCTTGAACCACAGCAGGATTC 
CLSA.1-1 At3g58640 At3g58640 - R TCTGTGAACGCAGATCAAATG 
CLSA.1-2 At2g31010 At2g31010 - F TGAGCTGTTTTCATCCTCTCG 
CLSA.1-2 At2g31010 At2g31010 - R ATACATTGGCACGACCTCTTG 
CLSA.1-3 At2g42640 At2g42640 - F TACACTGTGATCCCGGTAAGC 
CLSA.1-3 At2g42640 At2g42640 - R GAAGGGTTTAAGCTGACCAGG 
CLSB.1-2 At4g24480 At4g24480 - F CTCCACTTGTGGACTTTCAGG 
CLSB.1-2 At4g24480 At4g24480 - R TGAAACCTACTGATCCATGCC 
CLSB.2-1 At1g73660 At1g73660 - F TTTGGTCCAGTGAGGTTTTTG 
CLSB.2-1 At1g73660 At1g73660 - R ATGCGCATCATGAATAAGGAG 
CLSB.2-2 At1g18160 At1g18160 - F ACTCACAGTTCCATGCCAATC 
CLSB.2-2 At1g18160 At1g18160 - R GTCAGCGGAACATCGTTCTAG 
CLSB.2-3 At5g11850 At5g11850 - F GTTACTCGTCCCCCAAATTTC 
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CLSB.2-3 At5g11850 At5g11850 - R TCAAACTTTGCATCAGCTGTG 
CLSB.2-4 At1g08720 At1g08720 - F AAAACTCCTTGGTTCTTTGGC 
CLSB.2-4 At1g08720 At1g08720 - R CTCGATAACCTCTGGGCTACC 
        
    LBb1.3 ATTTTGCCGATTTCGGAAC 
    LB1 GCCTTTTCAGAAATGGATAAATAGCCTTGCTTCC 
 
Table 3. Cas9 editing results in CLSA.1 T1 plants.  
CRISPR Event # Generation Target 1 Target 2 Target 3 
CLSA.1 1-1 T1 N N N 
CLSA.1 3-1 T1 N N N 
CLSA.1 3-2 T1 N N N 
CLSA.1 3-3 T1 N N N 
CLSA.1 4-2 T1 N N N 
CLSA.1 4-3 T1 N Y N 
CLSA.1 5-1 T1 N N N 
CLSA.1 5-2 T1 N N N 
CLSA.1 5-3 T1 N N N 
CLSA.1 5-4 T1 N N N 
CLSA.1 7-1 T1 N N N 
CLSA.1 9-1 T1 N N N 
CLSA.1 9-2 T1 N N N 
 
Table 4. Cas9 editing results in CLSB.1 T1 plants.  
CRISPR Event # Generation Target 1 Target 2 
CLSB.1 5-1 T1 N N 
CLSB.1 6-1 T1 N N 
CLSB.1 6-2 T1 N N 
CLSB.1 6-3 T1 N N 
CLSB.1 7-1 T1 N N 
CLSB.1 7-2 T1 N N 
CLSB.1 8-2 T1 N N 
CLSB.1 9-1 T1 N N 
CLSB.1 10-1 T1 N N 






Table 5.  Cas9 editing results in CLSB.2 T1 plants. 
CRISPR Event # Generation Target 1 Target 2 Target 3 Target 4 
CLSB.2 1-1 T1 N N N Y 
CLSB.2 2-1 T1 N N N Y 
CLSB.2 2-2 T1 N N N Y 
CLSB.2 3-1 T1 N N N Y 
CLSB.2 3-2 T1 N N N Y 
CLSB.2 3-3 T1 N N N Y 
CLSB.2 4-1 T1 N N N Y 
CLSB.2 5-1 T1 N N N Y 
CLSB.2 5-2 T1 N N N Y 
CLSB.2 6-1 T1 N N N Y 
CLSB.2 7-1 T1 N N N Y 
CLSB.2 8-1 T1 N N N Y 
CLSB.2 8-2 T1 N N N Y 
 
Table 6. Cas9 editing results in CLSA.1 T2 plants.  
CRISPR Event # Generation Target 1 Target 2 Target 3 
CLSA.1 3-1-1 T2 N N N 
CLSA.1 3-1-2 T2 N N N 
CLSA.1 3-1-3 T2 N N N 
CLSA.1 3-1-4 T2 N N N 
CLSA.1 3-1-5 T2 N N N 
CLSA.1 3-1-6 T2 N N N 
CLSA.1 3-1-7 T2 N N N 
CLSA.1 9-1-1 T2 N N N 
CLSA.1 9-1-2 T2 N N N 
CLSA.1 9-1-3 T2 N N N 
CLSA.1 9-1-4 T2 N N N 
CLSA.1 9-1-5 T2 N N N 
CLSA.1 9-1-6 T2 N N N 
CLSA.1 9-1-7 T2 N N N 
CLSA.1 9-2-1 T2 N N N 
CLSA.1 9-2-2 T2 N N N 
CLSA.1 9-2-3 T2 N N N 
CLSA.1 9-2-4 T2 N N N 
CLSA.1 9-2-5 T2 N Y N 
CLSA.1 9-2-6 T2 N N N 






Table 7.  Cas9 editing results in CLSB.1 T2 plants. 
CRISPR Event # Generation Target 1 Target 2 
CLSB.1 6-1-1 T2 N N 
CLSB.1 6-1-2 T2 N N 
CLSB.1 6-1-3 T2 N N 
CLSB.1 6-1-4 T2 N N 
CLSB.1 6-1-5 T2 N N 
CLSB.1 6-1-6 T2 N N 
CLSB.1 6-1-7 T2 N N 
CLSB.1 6-2-1 T2 N N 
CLSB.1 6-2-2 T2 N N 
CLSB.1 6-2-3 T2 N N 
CLSB.1 6-2-4 T2 N N 
CLSB.1 6-2-5 T2 N N 
CLSB.1 6-2-6 T2 N N 
CLSB.1 6-2-7 T2 N N 
CLSB.1 6-3-1 T2 N N 
CLSB.1 6-3-2 T2 N N 
CLSB.1 6-3-3 T2 N N 
CLSB.1 6-3-4 T2 N N 
CLSB.1 6-3-5 T2 N N 
CLSB.1 6-3-6 T2 N N 
CLSB.1 6-3-7 T2 N N 
CLSB.1 7-1-1 T2 N N 
CLSB.1 7-1-2 T2 N N 
CLSB.1 7-1-3 T2 N N 
CLSB.1 7-1-4 T2 N N 
CLSB.1 7-1-5 T2 N N 
CLSB.1 7-1-6 T2 N N 
CLSB.1 7-1-7 T2 N N 
CLSB.1 7-2-1 T2 N N 
CLSB.1 7-2-2 T2 N N 
CLSB.1 7-2-3 T2 N N 
CLSB.1 7-2-4 T2 N N 
CLSB.1 7-2-5 T2 N N 
CLSB.1 7-2-6 T2 N N 







Table 8.  Cas9 editing results in CLSB.2 T2 plants. 
CRISPR Event # Generation Target 1 Target 2 Target 3 Target 4 
CLSB.2 1-1-1 T2 N N N Y 
CLSB.2 1-1-2 T2 N N N Y 
CLSB.2 1-1-3 T2 N N N Y 
CLSB.2 1-1-4 T2 N N N Y 
CLSB.2 1-1-5 T2 N N N Y 
CLSB.2 1-1-6 T2 N N N Y 
CLSB.2 1-1-7 T2 N N N Y 
CLSB.2 2-1-1 T2 N N N Y 
CLSB.2 2-1-2 T2 N N N Y 
CLSB.2 2-1-3 T2 N N N Y 
CLSB.2 2-1-4 T2 N N N Y 
CLSB.2 2-1-5 T2 N N N Y 
CLSB.2 2-1-6 T2 N N N Y 
CLSB.2 2-1-7 T2 N N N Y 
CLSB.2 2-2-1 T2 N N N Y 
CLSB.2 2-2-2 T2 N N N Y 
CLSB.2 2-2-3 T2 N N N Y 
CLSB.2 2-2-4 T2 N N N Y 
CLSB.2 2-2-5 T2 N N N Y 
CLSB.2 2-2-6 T2 N N N Y 
CLSB.2 2-2-7 T2 N N N Y 
 
Table 9. Guide RNA sequence used in the CRISPR-Cas9 construct for each CLS target gene. 
Target Gene Guide RNA Sequence 
CLSA.1-1 At3g58640 tgctctgatggcccagcatcc 
CLSA.1-2 At2g31010 tacacaccagggatcagaac 
CLSA.1-3 At2g42640 gacatacaggcacgtatatc 
CLSB.1-1 At5g03730 ccaccgctaggatcccaatc 
CLSB.1-2 At4g24480 cggaaagaagtaagtagtcc 
CLSB.2-1 At1g73660 gttgatcattgttctagcatc 
CLSB.2-2 At1g18160 tcgtctcgttgattgggcgtc 
CLSB.2-3 At5g11850 cgacaatgccgagactggat 








Table 10. CLS mutants identified through T-DNA insertion and CRISPR-Cas9 editing methods 
CLS Target Gene T-DNA het/homo editing CRISPR het/homo editing 
CLSA.1-1 AT3G58640 homozygous homozygous 
CLSA.1-2 AT2G31010 homozygous homozygous 
CLSA.1-3 AT2G42640 TBD homozygous 
CLSB.1-1 AT5G03730 TBD TBD 
CLSB.1-2 AT4G24480 heterozygous TBD 
CLSB.2-1 AT1G73660 homozygous TBD 
CLSB.2-2 AT1G18160 homozygous TBD 
CLSB.2-3 AT5G11850 homozygous TBD 
CLSB.2-4 AT1G08720 homozygous homozygous 
 
Table 11. Cas9 editing results in CLSA.1 heat-stressed plants 
CRISPR Event # Generation Target 1 Target 2 Target 3 
CLSA.1 4-3-1 T2 Y Y Y 
CLSA.1 4-3-2 T2 Y Y Y 
CLSA.1 4-3-3 T2 Y Y Y 
CLSA.1 9-2-5-1 T3 Y Y Y 










Figure 1. Cytokinin signaling pathway in Arabidopsis thaliana.  
Cytokinin binds to the CHASE domain of a histidine kinase receptor (AHK), which the phosphorelay event 
in which a phosphate is transferred from the AHK to an aspartate residue to the histidine phosphotransfer 






Figure 2. Ethylene signaling pathway. 
In the absence of ethylene, the Ser/Thr kinase CTR1 functions to phosphorylate and target EIN2 for 
degradation, which inactivates ethylene response genes. Adapted from Ju, 2015 Plant Physiology. 
 
Figure 3. CLS gene phylogenetic tree. 








Figure 4. dCAPs gel results for CLSB.2 T1 and T2’s for CLSB.2 target 4 (AT1G08720). 
Gel results showing editing in the EDR1 gene in CLSB.2 T1 and T2 plants compared to digested (C) and 




Figure 5. CRISPR construct. 





Figure 6. Transparent testa phenotype. 
Seeds from the T-DNA insertion mutant for the AT2G31010 gene showing the mutant yellow seed 
phenotype (right) compared to the wild-type brown seed phenotype (left). 
 
 
Figure 7. dCAPs gel results for CLSA.1 T1 and T2’s for CLSA.1 target 2 (AT2G31010). 
The gel results from the dCAPs analysis show that the plants CLSA.1 4-3 and 9-2-5 contain Cas9 editing at 




Figure 8. Gel for T-DNA insertion editing for AT1G73660 
Gel showing that plant 9 was homozygous for the T-DNA insertion, plants 3, 4, 5, 6, and 10 were 
heterozygous for the mutation, and plants 1, 2, and 7 were wild-type (plant 8 DNA did not amplify) 
compared to Col-0 lines 14 and 15. 
 
Figure 9. dCAPs gel results for CLSA.1 T2 and T3 treated with heat stress for all targets 
Gel showing homozygous mutation in all three CLSA.1 targets for all five plants tested compared to 
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